Skip to main content

Table 4 Summary of Steady-State Trough Concentrations of Plasma Alpha1-PI Determined by Content [Antigenic] Assay

From: Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized study

 

Prolastin-C 60 mg/kg

Prolastin 60 mg/kg

Mean Ctrough, μM (% CV)

16.9 (14)

16.7 (16)

 

n = 23

n = 24

Subjects with mean Ctrough ≥ 11 μM

23/23 (100%)

24/24 (100%)

  1. One subject missed a Prolastin-C infusion at Week 8. Therefore, only 23 data sets were available for determination of Ctrough following Prolastin-C treatment.
Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904